Exostar and BT Upgrade Relationship with New Alliance Agreement

Exostar and BT Upgrade Relationship with New Alliance Agreement

Alliance will enable secure collaborative research environments in the cloud for Life Sciences organizations and their partners worldwide

October 14, 2014

HERNDON, Va.--()--Exostar and BT today announced that Exostar has become a Specialist Member of the BT for Life Sciences partner ecosystem. Exostar's secure identity and access management (IAM) and enterprise federation solutions can now be paired with BT's 'Workbench Informatics' solution for scientists.

With the Exostar IAM solution as a secure access point, BT's Life Sciences customers can now utilize a virtual scientist's workbench in the cloud and collaborate with hundreds of partners and third-party applications throughout the Exostar Life Sciences community.

This platform will also provide heightened security for user information and intellectual property, ensuring organizations and individuals can now collaborate with confidence when sensitive and valuable information is involved. Exostar's Life Sciences Identity Hub is the scalable, proven solution where asset owners maintain control over access, which the Identity Hub enforces while offering individuals a single sign-on user experience.

BT for Life Sciences provides cloud-based solutions that enable customers to do better, faster science, radically reducing the time required for the R&D process. BT's Workbench Informatics solution brings together key applications and datasets, presented in a way that makes it easy for the scientist to launch virtual compute environments. This simplifies predictive simulations, allowing them to run faster and shortening the R&D discovery process. The service brings flexibility, including cost-effective pay-as-you-go and ramp up/ramp down options.

"BT and Exostar have become the 'go-to' choice for collaboration communities in Life Sciences," said Yury Rozenman, Head of Business Development, Life Sciences for BT Global Services. "By connecting BT's Workbench Informatics and other BT for Life Sciences solutions to the Exostar Life Sciences Identity Hub, companies can leverage access to a robust, global collaboration environment without compromising security."

Exostar currently has more than 12,000 users, 550 organizations, 7 federated organizations and 18 federated applications in its Life Sciences community. Exostar is experiencing rapid growth in Life Sciences global collaboration, with member organizations including Merck, AstraZeneca and MedImmune, along with their contract research organization, academic, laboratory, and investigator partners. Exostar's Life Sciences Identity Hub has also recently been selected as the identity and access management platform by a consortium of BioPharma industry leaders.

"BT for Life Sciences offers an extremely powerful suite of solutions that enable Life Sciences organizations to more productively conduct critical activities throughout the drug R&D process," said Daniel Pfeifle, Exostar's Vice President of Sales and Marketing. "With connections to our Life Sciences Identity Hub, which provides strong authentication and single sign-on access to solutions, BT is increasing the potential utility of these tools exponentially by putting additional partner data, resources and applications in the hands of their customers."

About Exostar

Exostar powers secure business-to-business information sharing, collaboration and business process integration throughout the value chain. Exostar supports the complex trading needs of many of the world's largest companies in aerospace and defense, life sciences, and other industries. Exostar's cloud-based identity assurance products and business applications reduce risk, improve agility and strengthen trading partner relationships and profitability for over 100,000 companies in 150 countries worldwide. The Exostar community includes market leaders such as AstraZeneca, BAE Systems, Bell Helicopter, The Boeing Company, Computer Sciences Corporation, Lockheed Martin Corp., Merck, Newport News Shipbuilding, Northrop Grumman, Raytheon Co. and Rolls-Royce. For more information, please visit www.exostar.com.

Contacts

Press Inquiries
Exostar
Alan Gilbert
703-793-7735 (o)
703-624-4675 (m)
[email protected]
or
BT
Kris Kozamchak
Head of PR and Corporate Relations U.S.
972-310-9055
[email protected]

 

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.